Tekla Healthcare Opportunities Fund Market Value
| THQ Fund | USD 18.91 0.11 0.58% |
| Symbol | Tekla |
Tekla Healthcare 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Tekla Healthcare's fund what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Tekla Healthcare.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Tekla Healthcare on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Tekla Healthcare Opportunities or generate 0.0% return on investment in Tekla Healthcare over 90 days. Tekla Healthcare is related to or competes with Tekla World, Red Oak, Baron Fifth, Baron Fifth, Schwab Balanced, Doubleline Yield, and Nuveen Credit. Abrdn Healthcare Opportunities Fund is a closed ended balanced mutual fund launched and managed by abrdn Inc More
Tekla Healthcare Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Tekla Healthcare's fund current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Tekla Healthcare Opportunities upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.07 | |||
| Information Ratio | 0.0547 | |||
| Maximum Drawdown | 5.79 | |||
| Value At Risk | (1.40) | |||
| Potential Upside | 2.23 |
Tekla Healthcare Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tekla Healthcare's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Tekla Healthcare's standard deviation. In reality, there are many statistical measures that can use Tekla Healthcare historical prices to predict the future Tekla Healthcare's volatility.| Risk Adjusted Performance | 0.1146 | |||
| Jensen Alpha | 0.0745 | |||
| Total Risk Alpha | 0.0299 | |||
| Sortino Ratio | 0.0556 | |||
| Treynor Ratio | 0.1736 |
Tekla Healthcare February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1146 | |||
| Market Risk Adjusted Performance | 0.1836 | |||
| Mean Deviation | 0.8259 | |||
| Semi Deviation | 0.8762 | |||
| Downside Deviation | 1.07 | |||
| Coefficient Of Variation | 714.96 | |||
| Standard Deviation | 1.09 | |||
| Variance | 1.18 | |||
| Information Ratio | 0.0547 | |||
| Jensen Alpha | 0.0745 | |||
| Total Risk Alpha | 0.0299 | |||
| Sortino Ratio | 0.0556 | |||
| Treynor Ratio | 0.1736 | |||
| Maximum Drawdown | 5.79 | |||
| Value At Risk | (1.40) | |||
| Potential Upside | 2.23 | |||
| Downside Variance | 1.15 | |||
| Semi Variance | 0.7677 | |||
| Expected Short fall | (0.88) | |||
| Skewness | 0.2282 | |||
| Kurtosis | 0.4751 |
Tekla Healthcare Opp Backtested Returns
Currently, Tekla Healthcare Opportunities is very steady. Tekla Healthcare Opp owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.1, which indicates the fund had a 0.1 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Tekla Healthcare Opportunities, which you can use to evaluate the volatility of the fund. Please validate Tekla Healthcare's Semi Deviation of 0.8762, coefficient of variation of 714.96, and Risk Adjusted Performance of 0.1146 to confirm if the risk estimate we provide is consistent with the expected return of 0.11%. The entity has a beta of 0.82, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Tekla Healthcare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Tekla Healthcare is expected to be smaller as well.
Auto-correlation | 0.09 |
Virtually no predictability
Tekla Healthcare Opportunities has virtually no predictability. Overlapping area represents the amount of predictability between Tekla Healthcare time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Tekla Healthcare Opp price movement. The serial correlation of 0.09 indicates that less than 9.0% of current Tekla Healthcare price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.09 | |
| Spearman Rank Test | 0.12 | |
| Residual Average | 0.0 | |
| Price Variance | 0.12 |
Pair Trading with Tekla Healthcare
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tekla Healthcare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tekla Healthcare will appreciate offsetting losses from the drop in the long position's value.Moving together with Tekla Fund
| 0.76 | SMPIX | Semiconductor Ultrasector | PairCorr |
| 0.79 | SMPSX | Semiconductor Ultrasector | PairCorr |
| 0.79 | RSNRX | Victory Global Natural | PairCorr |
| 0.82 | RSNYX | Victory Global Natural | PairCorr |
| 0.82 | RGNCX | Victory Global Natural | PairCorr |
The ability to find closely correlated positions to Tekla Healthcare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tekla Healthcare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tekla Healthcare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tekla Healthcare Opportunities to buy it.
The correlation of Tekla Healthcare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tekla Healthcare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tekla Healthcare Opp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tekla Healthcare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Tekla Fund
Tekla Healthcare financial ratios help investors to determine whether Tekla Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tekla with respect to the benefits of owning Tekla Healthcare security.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |